Patients with signs and symptoms of syphilis should undergo diagnostic testing. In patients with asymptomatic infection, diagnosis relies on routine screening.
Eliciting a history of sexual activity and risk factors is important when considering the diagnosis of syphilis. People at high risk of infection include those who have had sexual contact with an infected person, men who have sex with men (MSM), people infected with HIV or other STIs, people with multiple sexual partners, commercial sex workers, and people using illicit drugs. Pregnant women with syphilis are at risk of transmitting the infection transplacentally to the fetus.
It is important to establish whether a patient has a history of syphilis (and past treatment), as this can help with the interpretation of diagnostic test results and help confirm the stage of infection.
Signs and symptoms of primary syphilis
A solitary painless genital ulcer (chancre) in the anogenital or cervix area strongly suggests a diagnosis of primary syphilis. It may not always be noticed by the patient and examining physician, and it heals spontaneously. There may also be discrete, painless, rubbery regional lymphadenopathy. Mouth ulceration may occur in primary infection. When this occurs, the ulcer is confined to the mouth.
Atypically, ulceration may be multiple and painful. Co-infection with genital herpes or chancroid may be a cause of painful ulceration. Co-infection with HIV may result in multiple ulcers. Approximately 30% of HIV antibody-negative and 70% of HIV antibody-positive patients with primary syphilis have multiple genital ulcers.
Signs and symptoms of secondary syphilis
Patients may develop clinical features of secondary syphilis 4-8 weeks after primary syphilis infection. The presentation of secondary syphilis is diverse. The disseminated treponemal infection has multi-system manifestations. Patients may describe constitutional symptoms including fever, malaise, myalgia, fatigue, or arthralgia. They may also notice generalised lymphadenopathy. These features may be mistaken for an intercurrent viral illness or primary HIV infection. There may be a generalised symmetrical macular, papular, or maculopapular diffuse rash, typically affecting the palms of the hands and plantar aspects of the feet. The rash may also occur on the trunk and scalp. Occasionally the papules may ulcerate. There may be generalised mucosal ulceration, causing 'snail-track' ulcers on the buccal mucosa, and erosions on the genitalia. There may be flesh-coloured wart-like lesions in the genital area, known as condylomata lata. Patchy alopecia may develop.
Uncommon presentation includes specific organ involvement. Symptoms of headache, meningismus, hearing loss, seizures, or neuropathy suggest neurological involvement. Neurosyphilis may occur at any stage of infection with syphilis, and may occur in up to 10% of patients with untreated syphilis. Visual changes due to syphilitic iritis, uveitis, and choroidoretinitis may initially present to ophthalmological services. The vasculitis due to secondary syphilis may cause a nephrotic syndrome, glomerulonephritis, or hepatitis.
Up to 25% of people who have untreated secondary syphilis go on to develop relapsing episodes of secondary syphilis. Symptoms include rash and fever. These relapsing episodes rarely occur more than 1 year after acquiring syphilis.
Latent syphilis is defined as positive serology in the absence of clinical features of syphilis. Early latent syphilis is defined as asymptomatic infection that is diagnosed on the basis of positive serology alone, acquired <1 year previously (according to the Centers for Disease Control and Prevention [CDC]) or <2 years previously (according to the World Health Organization [WHO]).
Late latent syphilis is defined as asymptomatic infection that is acquired >1 year previously (CDC) or >2 years previously (WHO). The patient is not known to have been seronegative within the past year (CDC) or past 2 years (WHO).
Signs and symptoms of tertiary syphilis
It is estimated that 15% to 40% of patients with untreated syphilis progress to tertiary syphilis (late symptomatic disease). Tertiary syphilis is characterised by chronic, end-organ complications, often many years after initial infection. The diagnosis may be suspected from a past history of features of earlier-stage disease and the presence of risk factors.
Neurosyphilis may involve damage to the dorsal columns of the spinal cord, causing a syndrome known as tabes dorsalis. Features of tabes dorsalis include:
Loss of anal and bladder sphincter control
Dorsal column loss (loss of vibration and proprioception/position sense)
Brain involvement causes a range of syndromes, including cognitive and motor impairment, which are sometimes grouped under the broad term 'general paresis'. Features of general paresis may include:
A neurology or psychiatric consultation is required if neurosyphilis or brain involvement is suspected.
Cardiovascular syphilis usually affects the aortic root, causing an aortitis, which results in aortic regurgitation. Angina may arise as a result of coronary ostial stenosis. Aortic medial necrosis may cause aortic aneurysm. The cardiac murmur of aortic regurgitation and/or symptoms and signs of heart failure or aortic aneurysm on clinical examination require a cardiology consultation.
Gummatous syphilis (also known as benign tertiary syphilis) affects skin and visceral organs, causing organomegaly and infiltrative or destructive lesions, as well as perforation or collapse of affected structures. Gumma lesions consist of granulomatous rubbery tissue with a necrotic centre. The destructive lesions may gradually replace normal tissue. Gummata are an extremely rare manifestation of late syphilis, with the most common presentation being chronic skin ulceration and nodular infiltration.
Primary syphilis: larger, painful multiple ulcers.
Secondary syphilis: genital ulcers more common and higher titres with rapid plasma reagin (RPR) testing and Venereal Disease Research Laboratory (VDRL) testing.
Possibly more rapid progression to neurosyphilis.
Serological responses to infection may be atypical.
Signs and symptoms of congenital syphilis
Congenital syphilis occurs when the fetus acquires the infection transplacentally from the mother. This may result in miscarriage, stillbirth, or neonatal death. Intrauterine features such as hydrops may be detected on fetal ultrasound scanning. Postnatal manifestations are divided into early and late stages; early manifestations occur in the first 2 years of life, and late manifestations occur after 2 years of age.
The diagnosis of congenital syphilis is suspected, taking into account various factors, including:
Identification of syphilis in the mother
Adequacy of maternal treatment
Presence of clinical, laboratory, or radiographic evidence of syphilis in the infant (testing should include paired maternal and neonatal non-treponemal serological titres using the same test, preferably conducted at the same laboratory).
Most clinical signs are not visible at birth, but usually develop within 3 months. A highly infectious rhinitis, which may be purulent or blood-stained, may persist and is one of the earliest signs. Other early signs (occurring within 2 years) include hepatosplenomegaly, glomerulonephritis and nephrotic syndrome, generalised lymphadenopathy, central nervous system (CNS) involvement (including cerebrospinal fluid [CSF] abnormalities and syphilitic meningitis), and bone involvement (e.g., osteochondritis). A neonatal skin rash may occur and may be similar to the rash of secondary syphilis in adults. It may also be more widespread, bullous or papulonecrotic, or desquamating. Initially, the rash may be vesicular with small blisters appearing on the palms and plantar surfaces of the feet. An erythematous or maculopapular rash, which is often copper-coloured, may subsequently appear on the face, palms, and plantar surfaces of the feet. Necrotising funisitis (inflammation of the umbilical cord) is virtually diagnostic of congenital syphilis and is found usually in pre-term infants who are stillborn, or die within a few weeks of birth. The umbilical cord has a specific appearance known as the 'barberpole' cord as a result of inflammation of the matrix of the umbilical cord.
Untreated congenital syphilis may present late (after age 2 years). It is important to distinguish late congenital syphilis from postnatally acquired syphilis, as the latter raises the suspicion of child sexual abuse and should be investigated further.
Late congenital syphilis has several distinct findings, including:
Peg-shaped central incisors, notched at the apex (Hutchinson's teeth)
Eighth cranial nerve deafness
Frontal bossing of the skull
Anterior bowing of the shins (Saber shins)
Saddle nose deformity
Clutton's joints (symmetric painless knee swelling).
Interstitial keratitis, Hutchinson's teeth, and eighth cranial nerve deafness are collectively known as Hutchinson's triad.
Initial investigations for acquired syphilis
Culture of Treponema pallidum in vitro is not possible. Dark-field microscopy of the skin lesion can provide a definitive diagnosis of syphilis, but this test is not usually available outside specialist settings. The lesion is cleansed and abraded with a gauze pad until serous exudates appear, which are then collected onto a glass slide for microscopic analysis. Identification of T pallidum from the sample allows for immediate diagnosis. A single negative result does not exclude infection as collection of the treponemes is operator-dependent. A lesion is considered negative for T pallidum if microscopy on three different days is negative. Sensitivity of dark-field microscopy for genital ulcers is 74% to 86% and specificity is 85% to 100%.
For secondary syphilis, dark-field microscopy may be positive from skin or ulcerative anogenital lesions. However, gummata in tertiary syphilis have few, if any, identifiable T pallidum organisms. If available, dark-field microscopy should also be performed on any lesions or nasal discharge in infants with possible congenital syphilis.
Serology testing is the most commonly used method for diagnosing syphilis. It should be performed in all patients with signs or symptoms of syphilis (e.g., a painless anogenital ulcer). Serology testing requires the use of both treponemal (specific) and non-treponemal (non-specific) tests. The most common approach is to use a treponemal test as the initial serological test, followed by a non-treponemal test if the treponemal test is positive (i.e., a ‘reverse sequence screening algorithm’). This approach reduces time and costs compared with using a non-treponemal test as the initial serology test.
Treponemal tests include:
Treponemal enzyme immunoassay (EIA)
T pallidum particle agglutination assay (TPPA)
T pallidum haemagglutination assay (TPHA)
Fluorescent antibody absorption (FTA-ABS)
Immunocapture assay (ICA).
Treponemal tests are antigen-based tests and work by detecting antibodies to T pallidum. A patient with a positive treponemal test result will remain positive for life, irrespective of current or past infection. Therefore, a positive result alone cannot distinguish between an active infection (i.e., currently untreated or incompletely treated) and a past (treated) infection. Another limitation is that false-positive results may occur in the presence of diseases caused by non-sexually transmitted treponemal infections (e.g., yaws, pinta, bejel). False-negative results may occur in incubating and early primary syphilis.
A non-treponemal test should always be undertaken following a positive treponemal test to confirm a diagnosis and provide evidence of active disease or re-infection. Non-treponemal tests include:
The RPR test is usually the test of choice due to ease of use and interpretation. Non-treponemal tests work by detecting the antibody response to the release of cardiolipin during syphilis infection. These tests can provide a quantitive measure of disease activity (titre) and can be used to monitor treatment response. RPR and VDRL titres decrease or become non-reactive with effective treatment. A titre of ≥32 is rarely seen in adequately treated infection. Despite adequate treatment, some patients maintain a persisting low level positive antibody titre (known as a serofast reaction). False positives may occur due to the presence of a variety of medical conditions, such as pregnancy, autoimmune disorders, and other infections. A false-negative test may occasionally occur in an undiluted specimen (the prozone phenomenon).
If the non-treponemal test is negative, then a different treponemal test should be performed to confirm the results of the initial treponemal test.
The same non-treponemal test should be used sequentially when monitoring treatment response. This is because results obtained from one test are not directly comparable with that of the next non-treponemal test. A fourfold change in titre, equivalent to a change of two dilutions (e.g., from 1:16 to 1:4 or from 1:8 to 1:32), signifies a clinically significant difference between two non-treponemal test results.
There is evidence that the majority of patients with HIV who are treated for syphilis will have persistently positive non-treponemal titres (i.e., they are serofast), despite a fourfold decrease in titres as a result of treatment.
Incubation periods (usual time after infection that the test becomes positive) for treponemal and non-treponemal tests are as follows.
EIA: 3 weeks
TPPA: 4-6 weeks
TPHA: 4-6 weeks.
RPR: 4 weeks
VDRL: 4 weeks.
Patients with secondary syphilis will have strongly positive syphilis serological tests. Delayed seroreactivity or false-negative non-treponemal serology may rarely occur if there is HIV co-infection.
Patients with early or late latent syphilis may be detected as part of screening blood tests (e.g., prior to blood donation). EIA is the serological treponemal test generally used for screening. In late latent syphilis, treponemal tests are always positive.
In tertiary syphilis, positive serology will suggest a diagnosis already suspected from the history and clinical signs.
Other initial investigations for acquired syphilis
Line immunoassay (LIA) serological tests (e.g., INNO-LIA Syphilis test) can be used to confirm syphilis infection following initial serological treponemal testing. A single LIA test can confirm infection, making it more convenient than traditional methods of serological confirmation, which usually require performing multiple assays. Studies evaluating the performance of LIA tests for syphilis infection have demonstrated higher sensitivity and specificity compared with FTA-ABS and TPHA serology tests.
Compared with current tests (e.g., serology, dark-field microscopy), polymerase chain reaction (PCR) testing for T pallidum using samples taken directly from ulcerative lesions has been found to be moderately sensitive (70% to 80%) and highly specific (>90%) for diagnosing primary and secondary syphilis. The CDC considers PCR testing a valid method for diagnosing primary and secondary syphilis, and its use is likely to increase.
Point of care (POC) serological testing with either treponemal or combination treponemal/non-treponemal tests has been assessed in the setting of high-risk regions, where rapid and early diagnosis may be more important than accuracy. Several clinical trials have shown promise and POC testing has been recommended as part of the Pan American Health Organization strategy to diagnose and treat syphilis.
Further investigations for acquired syphilis
A lumbar puncture and CSF examination should be performed in any patient with clinical evidence of neurosyphilis (e.g., headache, meningismus, ophthalmic or auditory symptoms, cranial nerve palsies, motor or sensory deficits, seizures, or cognitive dysfunction). CNS involvement can occur at any stage of syphilis and can range from asymptomatic meningeal involvement to dementia and sensory neuropathy. A computed tomography or magnetic resonance imaging brain scan should be performed first if there is concern regarding raised intracranial pressure (i.e., mainly to ensure that undertaking a lumbar puncture is safe). A lumbar puncture is also indicated if syphilis of unknown duration is diagnosed in the presence of HIV co-infection. Neurosyphilis is suggested by:
CSF white blood cell (WBC) count >10 cells/mm³ (10 × 10⁶ cells/L)
CSF protein >50 mg/dL (0.50 g/L)
A positive CSF VDRL test.
The CSF will also demonstrate a positive TPHA, TPPA, or FTA-ABS treponemal test. A non-reactive CSF-TPHA test result usually excludes neurosyphilis. Neurological involvement is unlikely at CSF TPHA or TPPA titres <1:320. CSF examination should be repeated every 6 months until the CSF WBC count is normal if elevated on the initial sample.
Diagnostic lumbar puncture in adults: animated demonstration
A chest x-ray should be performed in people with syphilis of unknown duration, and in those who have had syphilis for more than 2 years, whether or not they have had cardiac symptoms. This may detect possible aortic aneurysm or aortic calcification. Any patient with suspected aortic regurgitation, heart failure, or aortic aneurysm will require both a chest x-ray and echocardiogram.
All patients with syphilis should be tested for HIV. In geographical areas in which the prevalence of HIV is high, patients who have primary syphilis should be re-tested for HIV after 3 months, even if the first HIV test result is negative. Hence a low threshold for the testing and treatment of syphilis in patients with HIV is advisable.
Initial investigations for congenital syphilis
The CDC has published recommendations concerning serological tests required in the diagnosis of congenital syphilis. Syphilis serology should be performed on all pregnant women at the first antenatal visit. Serology should be repeated again early in the third trimester and at delivery if serology has been positive, or if there is high maternal risk of syphilis acquisition. The syphilis serological status of the mother should be determined during pregnancy and prior to discharge of the infant from hospital. Any woman who delivers a stillborn infant should be tested for syphilis. All pregnant women who have syphilis should also be tested for HIV. All infants who are born to mothers with positive serology require a non-treponemal test (VDRL or RPR), which should be performed on the infant's serum rather than on umbilical cord blood.
Further investigations for congenital syphilis
Pregnant women with syphilis or suspected of having syphilis require a fetal ultrasound scan. The presence of fetal or placental syphilis (e.g., hepatomegaly, ascites, hydrops fetalis) indicates a greater risk of treatment failure for congential syphilis.
After birth, lumbar puncture with CSF analysis for WBC count, protein (and VDRL), full blood count, and other tests as clinically indicated (e.g., chest x-ray, cranial ultrasound, long-bone x-rays, liver function tests, auditory brainstem response) are recommended by the CDC in the following cases:
Infants (aged <1 month) with confirmed or highly probable disease plus:
An abnormal physical examination that is consistent with congenital syphilis or
A serum quantitative non-treponemal serological titre that is fourfold higher than the mother's titre or
A positive dark-field or fluorescent antibody test of body fluid.
Infants (aged <1 month) who have a normal physical examination and a serum quantitative non-treponemal serological titre the same or less than fourfold the maternal titre plus:
The mother was not treated, was inadequately treated, or has no documentation of having received treatment or
The mother was treated with erythromycin or other non-penicillin regimen or
The mother received treatment <4 weeks before delivery.
Children aged >1 month with reactive serological tests and at risk of congenital syphilis. These children should also have an HIV test.
Use of this content is subject to our disclaimer